GlassScriptPhysician profile
Edward R Alexson
NPI 1154363141
$2,233.56
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,947 · 2020: $287.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $289.33 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $259.61 | 2019 | |
| Lilly USA, LLC | $241.45 | 2019 | |
| Genentech USA, INC. | $169.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $159.77 | 2019-2020 | |
| Astellas Pharma US INC | $136.36 | 2019-2020 | |
| Pfizer INC. | $136.31 | 2019 | |
| Janssen Biotech, INC. | $121.34 | 2019 | |
| Alexion Pharmaceuticals, INC. | $120.35 | 2020 | |
| Pharmacyclics LLC, An Abbvie Company | $117.26 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $110.03 | 2019 | |
| Amgen INC. | $92.74 | 2019 | |
| Abbvie INC. | $65.15 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.51 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.84 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $32.69 | 2019 | |
| Verastem, INC. | $23.63 | 2020 | |
| Genzyme Corporation | $18.71 | 2019 | |
| Partner Therapeutics, INC. | $17.05 | 2019 | |
| Array Biopharma INC | $16.73 | 2019 | |
| Puma Biotechnology, INC. | $16.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $6.25 | 2019 | |
| Sirtex Medical INC | $5.99 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Alexson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.